Pfizer Inc (NYSE:PFE), an American multinational Pharmaceutical company headquartered in New York, announced on Thursday that its board of directors has declared a USD0.38 per share fourth-quarter 2020 dividend on the company's common stock.
The dividend is payable 1 December 2020, to holders of the Common Stock of record at the close of business on 6 November 2020.
The fourth-quarter 2020 cash dividend will be the 328th consecutive quarterly dividend paid by Pfizer.
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
Abbott announces quarterly common dividend
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli